bcl-2 expression in endometrial hyperplasia and carcinoma

被引:33
|
作者
Niemann, TH
Trgovac, TL
McGaughy, VR
Vaccarello, L
机构
[1] ARTHUR G JAMES CANC HOSP,COLUMBUS,OH 43210
[2] OHIO STATE UNIV,MED CTR,DIV GYNECOL ONCOL,COLUMBUS,OH 43210
关键词
D O I
10.1006/gyno.1996.0329
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The bcl-2 gene codes for a protein which functions to inhibit apoptotic cell death. bcl-2 overexpression was originally described in follicular lymphoma, but more recently bcl-2 expression has been observed in a variety of other human neoplasms. In this study we used immunohistochemistry to examine bcl-2 protein expression in endometrial hyperplasia and carcinoma. bcl-2 protein was observed in 4/4 cases of complex hyperplasia, 1/4 cases of complex atypical hyperplasia, and 10/29 cases of carcinoma. The staining observed in the cases of complex atypical hyperplasia and carcinoma was focal and less intense than the reactivity of normal proliferative endometrium. We conclude that bcl-2 protein is seldom overexpressed in complex atypical hyperplasia or carcinoma of the endometrium. Rather, in many cases of endometrial carcinoma bcl-2 expression appears to be decreased. (C) 1996 Academic Press, Inc.
引用
收藏
页码:318 / 322
页数:5
相关论文
共 50 条
  • [31] Bcl-2 expression in oral squamous cell carcinoma
    Popovic, B.
    Jekic, B.
    Novakovic, I.
    Lukovic, L. J.
    Tepavcevic, Z.
    Jurisic, V.
    Vukadinovic, M.
    Milasin, J.
    SIGNAL TRANSDUCTION PATHWAYS, PT C: CELL SIGNALING IN HEALTH AND DISEASE, 2007, 1095 : 19 - 25
  • [32] Immunohistochemical expression of Bax and Bcl-2 in penile carcinoma
    Saeed, S
    Keehn, CA
    Khalil, FK
    Morgan, MB
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2005, 35 (01): : 91 - 96
  • [33] BCL-2 protein expression in ductal carcinoma in situ
    Quinn, CM
    Ostrowski, JL
    Harkins, L
    JOURNAL OF PATHOLOGY, 1997, 181 : A22 - A22
  • [34] BCL-2 ONCOPROTEIN EXPRESSION IN HEPATOCELLULAR-CARCINOMA
    SUZUKI, K
    HAYASHI, N
    ITO, Y
    NAKASE, H
    NODA, K
    ARAI, Y
    ENOMOTO, N
    ARAI, K
    YAMADA, Y
    TANAKA, M
    YOSHIHARA, H
    YOSHIKAWA, K
    SASAKI, Y
    FUSAMOTO, H
    KAMADA, T
    GASTROENTEROLOGY, 1994, 106 (04) : A992 - A992
  • [35] Heterogeneity of Bcl-2 expression in metastatic breast carcinoma
    Subhawong, Andrea Proctor
    Nassar, Hind
    Halushka, Marc K.
    Illei, Peter B.
    Vang, Russell
    Argani, Pedram
    MODERN PATHOLOGY, 2010, 23 (08) : 1089 - 1096
  • [36] Apoptosis and the expression of Bax and Bcl-2 in hyperplasia and adenocarcinoma of the uterine endometrium
    Kokawa, K
    Shikone, T
    Otani, T
    Nishiyama, R
    Ishii, Y
    Yagi, S
    Yamoto, M
    HUMAN REPRODUCTION, 2001, 16 (10) : 2211 - 2218
  • [37] Differential expression of antiapoptotic genes in human endometrial carcinoma:: bcl-XL succeeds bcl-2 function in neoplastic cells
    Crescenzi, E
    Criniti, V
    Pianese, M
    Tecce, MF
    Palumbo, G
    GYNECOLOGIC ONCOLOGY, 2000, 77 (03) : 419 - 428
  • [38] Expression of bcl-2, bax, bcl-xL, and bcl-xS, in endometrial and cervical tissues
    Mozzetti, S
    Ferrandina, G
    Marone, M
    D'Ingiullo, F
    Fruscella, E
    De Pasqua, A
    Mancuso, S
    Scambia, G
    CANCER DETECTION AND PREVENTION, 2000, 24 (06): : 536 - 541
  • [39] Analysis of bcl-2 protein expression and bcl-2/JH fusion gene formation in hepatocellular carcinoma
    Guo, LL
    Xiao, S
    Guo, Y
    HEPATOLOGY RESEARCH, 1998, 13 (01) : 55 - 61
  • [40] Bax, Bcl-2, and p53 expression in endometrial cancer
    Sakuragi, N
    Salah-eldin, A
    Watari, H
    Itoh, T
    Inoue, S
    Moriuchi, T
    Fujimoto, S
    GYNECOLOGIC ONCOLOGY, 2002, 86 (03) : 288 - 296